MYC and Ewing sarcoma: Furthermore, xenograft of control and shMYC TC71 Ewing sarcoma cellsinto immunodeficient mice (NOD/SCID/IL-2γ null) resulted in a significant decreasein volume and weight for the MYC knockdown tumors after 6 weeks of growth(Fig. 4D).